Rising Incidences of Ocular disorders to Make the Visual Electrophysiology Market Reach US$ 475.3 Mn at a CAGR of 7.2% During the Forecast Period of 2022-32 | Future Market Insights, Inc.
25 oct. 2022 11h45 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEWARK, Del: The global visual electrophysiology market is valued at US$ 220.3 Mn as of now and expected to reach US$ 475.3 Mn by the year 2032 at a...
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
24 oct. 2022 11h03 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Medical Center of Excellence to leverage the Company’s PURE EP™ System to further its research and educational objectives as a leader in cardiac...
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
12 oct. 2022 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
Global Electrophysiology Market to Hit Sales of $12.27 Billion by 2028 | Top 5 Players Holds 34% Market Share | SkyQuest Technology
10 oct. 2022 08h48 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Oct. 10, 2022 (GLOBE NEWSWIRE) -- As the population ages, the demand for electrophysiology market is expected to grow. This growth is being driven by the increasing prevalence of...
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base
07 oct. 2022 09h35 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
22 sept. 2022 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication
31 août 2022 08h00 HE
|
Volta Medical
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent...
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
30 août 2022 09h37 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
Global Medical Device Reprocessing Market (2022 to 2027) - Regulatory Changes Favoring Adoption of Medical Device Reprocessing Presents Opportunities
25 août 2022 08h48 HE
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical...
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
24 août 2022 09h17 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing...